Ligand validation:9MDH

IMN: INDOMETHACIN

IMN is a Ligand Of Interest in 9MDH designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
9MDH_IMN_C_406	55%	41%	0.11	0.878	1.17	1.11	2	2	2	0	100%	1
9MDH_IMN_D_406	39%	43%	0.139	0.846	1.18	1.05	2	1	2	0	100%	1
9MDH_IMN_A_411	30%	39%	0.156	0.817	1.17	1.23	2	1	2	0	100%	1
9MDH_IMN_B_406	27%	40%	0.162	0.807	1.18	1.17	2	2	2	0	100%	1
9MDF_IMN_A_402	24%	17%	0.151	0.78	1.7	1.87	3	7	2	0	100%	1
8YG7_IMN_I_602	95%	4%	0.072	0.974	1.76	4.05	5	13	10	0	100%	1
4YIA_IMN_B_401	71%	11%	0.101	0.922	1.42	2.71	3	14	0	0	100%	1
7FCG_IMN_A_200	66%	20%	0.115	0.919	1.56	1.85	5	8	1	0	100%	0.792
3UG8_IMN_A_2001	62%	10%	0.136	0.928	2.25	2.04	8	12	8	0	100%	0.7
4COX_IMN_A_701	61%	22%	0.155	0.945	1.87	1.37	7	2	8	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.